{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:03:47Z","timestamp":1780599827168,"version":"3.54.1"},"reference-count":27,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Validated gastrointestinal (GI) symptoms scales are used in clinical practice to assess patient-reported GI involvement. We sought to determine whether University of California, Los Angeles (UCLA) GI Tract Questionnaire (GIT) 2.0 Reflux scale, Patient-Reported Outcomes Measurement Information System (PROMIS) Reflux scale, and the Quality of Life in Reflux and Dyspepsia questionnaire (QOLRAD) are sensitive to identifying changes in GI symptoms following therapeutic intervention in participants with systemic sclerosis (SSc) and gastroesophageal reflux disease (GERD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Participants with active GERD were recruited during clinical visits at 6 international SSc centers. Patient-reported outcome surveys and the GI self-reported questionnaire were completed at baseline and again at 4 weeks following a single intervention, and patients were classified as \u201cimproved\u201d or \u201cnot improved.\u201d Effect size (ES) was calculated to assess the sensitivity to change. ES was interpreted as 0.50\u20130.79 as moderate effect and \u2265 0.80 as large effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>There were 116 participants with SSc and active GERD who enrolled. The average age was 53.8 years and mean disease duration was 12.0 years. The UCLA GIT 2.0 Reflux scale and PROMIS Reflux scale had a significant correlation at baseline (0.61, p &lt; 0.0001), and both instruments correlated with the QOLRAD domains (\u22120.56 to \u22120.71). In participants who had the UCLA GIT 2.0, PROMIS Reflux scale, and QOLRAD administered over 2 timepoints (n = 57) and were classified as improved, the ES was large for the UCLA GIT 2.0 and PROMIS Reflux scale, and moderate to large across all QOLRAD domains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The UCLA GIT 2.0 Reflux scale, PROMIS Reflux scale, and QOLRAD are sensitive to change and can be included in future clinical trials.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.180004","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T12:28:03Z","timestamp":1542284883000},"page":"78-84","source":"Crossref","is-referenced-by-count":18,"title":["Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease \u2014 Scleroderma Clinical Trials Consortium"],"prefix":"10.3899","volume":"46","author":[{"given":"Zsuzsanna H.","family":"McMahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Berrocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Melsens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"2019010716553441000_46.1.78.1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"2019010716553441000_46.1.78.2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s40674-014-0005-0","article-title":"Management of gastrointestinal involvement in scleroderma","volume":"1","author":"Nagaraja","year":"2015","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"2019010716553441000_46.1.78.3","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0217-3"},{"key":"2019010716553441000_46.1.78.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker110"},{"key":"2019010716553441000_46.1.78.5","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225549.19127.90"},{"key":"2019010716553441000_46.1.78.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.21261"},{"issue":"Suppl 86","key":"2019010716553441000_46.1.78.7","first-page":"S-98","article-title":"GERD questionnaire for diagnosis of gastroesophageal reflux disease in systemic sclerosis","volume":"32","author":"Chunlertrith","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2019010716553441000_46.1.78.8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrgastro.2017.130","article-title":"Expert consensus document: advances in the physiological assessment and diagnosis of GERD","volume":"14","author":"Savarino","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2019010716553441000_46.1.78.9","first-page":"302","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2019010716553441000_46.1.78.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41217.x"},{"key":"2019010716553441000_46.1.78.11","first-page":"56","article-title":"Quality of life in different gastrointestinal conditions","volume":"582","author":"Wiklund","year":"1998","journal-title":"Eur J Surg Suppl"},{"key":"2019010716553441000_46.1.78.12","first-page":"41","article-title":"Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD)","volume":"583","author":"Wiklund","year":"1998","journal-title":"Eur J Surg Suppl"},{"key":"2019010716553441000_46.1.78.13","doi-asserted-by":"publisher","DOI":"10.1002\/art.24730"},{"key":"2019010716553441000_46.1.78.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110225"},{"key":"2019010716553441000_46.1.78.15","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.237"},{"key":"2019010716553441000_46.1.78.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04142.x"},{"key":"2019010716553441000_46.1.78.17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s10620-017-4499-9","article-title":"Responsiveness to change and minimally important differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales","volume":"62","author":"Khanna","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2019010716553441000_46.1.78.18","doi-asserted-by":"publisher","DOI":"10.1007\/BF02310555"},{"key":"2019010716553441000_46.1.78.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.paid.2003.09.005"},{"key":"2019010716553441000_46.1.78.20","first-page":"832","article-title":"Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial","volume":"32","author":"Khanna","year":"2005","journal-title":"J Rheumatol"},{"key":"2019010716553441000_46.1.78.21","unstructured":"Cohen J . Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988."},{"key":"2019010716553441000_46.1.78.22","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000434668.32150.e5"},{"key":"2019010716553441000_46.1.78.23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01770.x"},{"key":"2019010716553441000_46.1.78.24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/00365528708991497","article-title":"Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis","volume":"22","author":"Stentoft","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"2019010716553441000_46.1.78.25","first-page":"763","article-title":"Gastrointestinal manifestations of progressive systemic sclerosis","volume":"92","author":"Lock","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"2019010716553441000_46.1.78.26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12876-015-0241-2","article-title":"Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study","volume":"15","author":"Arif","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 76","key":"2019010716553441000_46.1.78.27","first-page":"57","article-title":"Associations between a scleroderma-specific gastrointestinal instrument and objective tests of upper gastrointestinal involvements in systemic sclerosis","volume":"31","author":"Bae","year":"2013","journal-title":"Clin Exp Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.180004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T12:23:32Z","timestamp":1572697412000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.180004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,1]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.3899\/jrheum.180004"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.180004","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]}}}